Pyxis Oncology, Inc.PYXSNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank40
3Y CAGR-58.6%
5Y CAGR-0.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-58.6%/yr
Annual compound
5Y CAGR
-0.2%/yr
Recent deceleration
Percentile
P40
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $19.47M | +101.5% |
| 2023 | $9.66M | -94.6% |
| 2022 | $179.29M | -34.7% |
| 2021 | $274.74M | +3300.2% |
| 2020 | $8.08M | -59.0% |
| 2019 | $19.69M | - |